RecruitingPhase 1NCT06813118

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

A RCT Comparing the Effectiveness of a Combination Therapy of Lezra and Clomid Versus Lezra Alone for Inducing Ovulation in Women Diagnosed With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome


Sponsor

HITEC-Institute of Medical Sciences

Enrollment

42 participants

Start Date

Jun 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Clomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickness will be checked by transvaginal ultrasound and results will be recorded.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study compares two fertility medications — Clomid (clomiphene citrate) and Letrozole (sometimes called Lezra) — in women with polycystic ovary syndrome (PCOS) who have not responded to Clomid alone. PCOS is a hormonal condition that can make it harder to ovulate and get pregnant. Researchers want to find out if combining the two drugs works better than Letrozole on its own. **You may be eligible if...** - You are a woman between 20 and 40 years old - You have been diagnosed with PCOS - You have tried Clomid before but it did not help you ovulate **You may NOT be eligible if...** - Your ovaries have stopped working early (premature ovarian insufficiency) - Your partner has a very low or absent sperm count - You have an underactive thyroid (hypothyroidism) - You have high levels of the hormone prolactin (hyperprolactinemia) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGClomiphene Citrate and letrozole

clomiphene citrate 100mg once daily along with letrozole 5mg to one group and letrozole 5mg to second group


Locations(1)

HIT Hospital

Rawalpindi, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06813118


Related Trials